A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
About Beckman Research Institute Bookmark and Share

Beckman Research Institute of City of Hope

Nestled in the foothills of the San Gabriel Mountains, Beckman Research Institute was the first of five Beckman Institutes to be founded. The Beckman Institute at City of Hope is unique because it has held a National Cancer Institute Cancer Center Support Grant for more than 30 years.
 
It encompasses over 60 years of expertise in basic science that includes research at City of Hope prior to the establishment of the Institute by Arnold and Mabel Beckman in 1983. Faculty and investigators here revolutionize the treatment of life-threatening diseases. They are focused on investigating the biology, biological chemistry, and pathology of cancer and diabetes, and they examine the emerging links between the two. Researchers are committed to identifying opportunities at the cellular and molecular level to predict, prevent, diagnose, treat and cure these and other serious diseases.
 
Fundamental advances in understanding of acute illnesses translate into an improved armamentarium for clinicians at City of Hope, which for 10 years has been ranked a U.S.News & World Report Best Cancer Hospital.

Beckman Research Institute investigators examine a wide range of research areas that includes diabetes progression and treatment, immunology and imaging, interfering RNAs and HIV treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, DNA repair and radiation, and the immunobiology of viral infection.
 
In addition, the City of Hope NCI-Designated Comprehensive Cancer Center is comprised of five research programs in the areas of basic, translational, and prevention research: Cancer Biology, Developmental Cancer Therapeutics, Cancer Immunotherapeutics, Hematologic Malignancies, and Cancer Control & Population Sciences. These programs conduct activities across the entire Duarte campus facilitating interactions among researchers and clinicians of all disciplines.
 
 
 

Scientific Leadership and Administration

Beckman Research Institute Departments and Divisions

The Department of Cancer Biology offers a multidisciplinary research and training environment in molecular biology, genetics, epigenetics and developmental biology.
 
Dedicated to discovering immune-based cancer therapies, the Department of Cancer Immunotherapeutics & Tumor Immunology conducts research in a new and evolving field and is known particularly for its studies using genetically engineered T-cells.
 
This department focuses on understanding the genetic and molecular bases of diabetes, developing novel treatment approaches for diabetes and preventing associated diseases such as cancer, heart disease and stroke.
 
 
Immunology
With a dual focus on immunology and structural biology, the Department of Immunology explores cancer immunology and biochemistry, antigen processing and T cell development.
Maintaining a strong emphasis on the interface of chemistry and biology, the Department of Molecular and Cellular Biology focuses on gene structure, modeling of antibodies, theoretical biology and more.
Established in 1996, the Department of Molecular Medicine seeks to understand basic mechanisms underlying cancer and other diseases for the purpose of developing novel molecular therapeutics.
The Department of Molecular Pharmacology aims to bridge the gap between the development of promising new drugs and their application in the clinic.
 
The Department of Neurosciences focuses on a range of research related to the brain and nervous system, including studies of molecular neurobiology/neurochemistry, neurophysiology, neuromorphology and molecular genetics.
 
Department researchers collaborate to better understand the causes of cancer, improve outcomes and develop ways to prevent cancer through discoveries made in population studies, survivorship, patterns of care and more.
 
  • Division of Cancer Etiology
    The goal of the Division of Cancer Etiology is to understand the causes of cancer. By understanding the causes of cancer, solutions can be developed to help prevent cancer, especially in people who are at highest risk.
     
  • Division of Clinical Cancer Genetics
    The Division of Clinical Cancer Genetics includes clinical services, research, and educational programs focusing on people who are at increased risk for developing cancer because of family history or personal risk factors.
     
  • Division of Outcomes Research
    The goal of the Division of Outcomes Research is to better understand the after-effects (physical, emotional, and social) of cancer and its treatment.
    • Center for Cancer Survivorship
      This is a clinical long-term follow-up program designed to create a bridge between cancer treatment and community medical care.
       
  • Division of Nursing Research and Education
    The Division of Nursing Research and Education is well recognized on a national level for its research and education focused on nursing care for patients with cancer, which has helped to increase the quality of care provided to cancer patients across the United States.
The Department of Radiation Biology studies the fundamental mechanisms of cancers and radiation resistance in cancer cells to find a solution to improve the efficacy of radiation therapy.

Research in the Department of Virology supports eight faculty members and laboratories with research including viral vector development, viral immunology, and vaccine development. The program includes early phase clinical trials in gene transfer and in vaccine evaluation.

  • Translational Vaccine Research
    The Division of Translational Vaccine Research (TVR) develops vaccines to combat hematologic malignancies, solid tumors, and infectious pathogens such as CMV and HIV.
     
 

Research Department Chairs

Research Division Directors

Beckman Research Institute Milestones

2001
The Graduate School of Biological Sciences is accredited.

Fouad Kandeel, M.D., Ph.D., wins NIH approval for City of Hope as one of 10 national centers for isolating and distributing islet cells for transplantation into patients with Type 1 diabetes.


2005
The Division of Cancer Immunotherapeutics and Tumor Immunology is created.


2006
Arthur Riggs, Ph.D., is elected to the National Academy of Sciences in recognition of his work explaining how methylation modifies and changes the function of DNA.


2007
Groundbreaking on the Arnold and Mabel Beckman Center for Cancer Immunotherapeutics and Tumor Immunology.


2008
John Rossi, Ph.D., and John Zaia, M.D., open the first-in-human clinical trial for HIV related malignancies using a lentiviral vector to deliver a triple small RNA based gene therapy.

Richard Jove, Ph.D., is named director of the Beckman Research Institute.

Arthur Riggs, Ph.D., receives California Institute of Technology Distinguished Alumni Award.

The Department of Diabetes and Metabolic Diseases is created.
 

Beckman Research Institute Milestones

1984
The Beckman Research Institute is dedicated.

Arthur Riggs, Ph.D., and Shmuel Cabilly, Ph.D., demonstrate the feasibility and describe a method for making humanized monoclonal antibodies, technology later used in “smart” cancer drugs such as Herceptin, Rituxan and Avastin.


1988
Eugene Roberts, Ph.D., is elected to the National Academy of Sciences in recognition of his work on the existence and function of GABA and other neurotransmitters on the brain and nervous system.


1990
John Rossi, Ph.D., reports first use of RNA to block the progress of the virus that causes AIDS.


1994
The Graduate School of Biological Sciences is chartered.


1996
The Division of Molecular Medicine is created.

Gerd Pfeifer, Ph.D., definitively links smoking to lung cancer, identifying the genetic damage done by the active compounds in cigarettes.


1998
The Division of Molecular Biology is created.

Barry Forman, M.D., Ph.D., identifies the first new steroid-like hormone in 30 years, androstanol, a hormone that reverses or halts gene activity.


1999
The Division of Virology is created.

Arthur Riggs, Ph.D., is named Director of the Beckman Research Institute.


2000
The Center for Biomedicine & Genetics is established to ensure that City of Hope scientific discoveries are efficiently translated from the research lab to the clinical setting.

Beckman Research Institute Milestones

These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.
 

About Beckman Research Institute

Beckman Research Institute of City of Hope

Nestled in the foothills of the San Gabriel Mountains, Beckman Research Institute was the first of five Beckman Institutes to be founded. The Beckman Institute at City of Hope is unique because it has held a National Cancer Institute Cancer Center Support Grant for more than 30 years.
 
It encompasses over 60 years of expertise in basic science that includes research at City of Hope prior to the establishment of the Institute by Arnold and Mabel Beckman in 1983. Faculty and investigators here revolutionize the treatment of life-threatening diseases. They are focused on investigating the biology, biological chemistry, and pathology of cancer and diabetes, and they examine the emerging links between the two. Researchers are committed to identifying opportunities at the cellular and molecular level to predict, prevent, diagnose, treat and cure these and other serious diseases.
 
Fundamental advances in understanding of acute illnesses translate into an improved armamentarium for clinicians at City of Hope, which for 10 years has been ranked a U.S.News & World Report Best Cancer Hospital.

Beckman Research Institute investigators examine a wide range of research areas that includes diabetes progression and treatment, immunology and imaging, interfering RNAs and HIV treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, DNA repair and radiation, and the immunobiology of viral infection.
 
In addition, the City of Hope NCI-Designated Comprehensive Cancer Center is comprised of five research programs in the areas of basic, translational, and prevention research: Cancer Biology, Developmental Cancer Therapeutics, Cancer Immunotherapeutics, Hematologic Malignancies, and Cancer Control & Population Sciences. These programs conduct activities across the entire Duarte campus facilitating interactions among researchers and clinicians of all disciplines.
 
 
 

Scientific Leadership and Administration

Scientific Leadership and Administration

Departments and Divisions

Beckman Research Institute Departments and Divisions

The Department of Cancer Biology offers a multidisciplinary research and training environment in molecular biology, genetics, epigenetics and developmental biology.
 
Dedicated to discovering immune-based cancer therapies, the Department of Cancer Immunotherapeutics & Tumor Immunology conducts research in a new and evolving field and is known particularly for its studies using genetically engineered T-cells.
 
This department focuses on understanding the genetic and molecular bases of diabetes, developing novel treatment approaches for diabetes and preventing associated diseases such as cancer, heart disease and stroke.
 
 
Immunology
With a dual focus on immunology and structural biology, the Department of Immunology explores cancer immunology and biochemistry, antigen processing and T cell development.
Maintaining a strong emphasis on the interface of chemistry and biology, the Department of Molecular and Cellular Biology focuses on gene structure, modeling of antibodies, theoretical biology and more.
Established in 1996, the Department of Molecular Medicine seeks to understand basic mechanisms underlying cancer and other diseases for the purpose of developing novel molecular therapeutics.
The Department of Molecular Pharmacology aims to bridge the gap between the development of promising new drugs and their application in the clinic.
 
The Department of Neurosciences focuses on a range of research related to the brain and nervous system, including studies of molecular neurobiology/neurochemistry, neurophysiology, neuromorphology and molecular genetics.
 
Department researchers collaborate to better understand the causes of cancer, improve outcomes and develop ways to prevent cancer through discoveries made in population studies, survivorship, patterns of care and more.
 
  • Division of Cancer Etiology
    The goal of the Division of Cancer Etiology is to understand the causes of cancer. By understanding the causes of cancer, solutions can be developed to help prevent cancer, especially in people who are at highest risk.
     
  • Division of Clinical Cancer Genetics
    The Division of Clinical Cancer Genetics includes clinical services, research, and educational programs focusing on people who are at increased risk for developing cancer because of family history or personal risk factors.
     
  • Division of Outcomes Research
    The goal of the Division of Outcomes Research is to better understand the after-effects (physical, emotional, and social) of cancer and its treatment.
    • Center for Cancer Survivorship
      This is a clinical long-term follow-up program designed to create a bridge between cancer treatment and community medical care.
       
  • Division of Nursing Research and Education
    The Division of Nursing Research and Education is well recognized on a national level for its research and education focused on nursing care for patients with cancer, which has helped to increase the quality of care provided to cancer patients across the United States.
The Department of Radiation Biology studies the fundamental mechanisms of cancers and radiation resistance in cancer cells to find a solution to improve the efficacy of radiation therapy.

Research in the Department of Virology supports eight faculty members and laboratories with research including viral vector development, viral immunology, and vaccine development. The program includes early phase clinical trials in gene transfer and in vaccine evaluation.

  • Translational Vaccine Research
    The Division of Translational Vaccine Research (TVR) develops vaccines to combat hematologic malignancies, solid tumors, and infectious pathogens such as CMV and HIV.
     
 

Research Department Chairs

Research Department Chairs

Research Division Directors

Research Division Directors

Milestones: 2001 - Present

Beckman Research Institute Milestones

2001
The Graduate School of Biological Sciences is accredited.

Fouad Kandeel, M.D., Ph.D., wins NIH approval for City of Hope as one of 10 national centers for isolating and distributing islet cells for transplantation into patients with Type 1 diabetes.


2005
The Division of Cancer Immunotherapeutics and Tumor Immunology is created.


2006
Arthur Riggs, Ph.D., is elected to the National Academy of Sciences in recognition of his work explaining how methylation modifies and changes the function of DNA.


2007
Groundbreaking on the Arnold and Mabel Beckman Center for Cancer Immunotherapeutics and Tumor Immunology.


2008
John Rossi, Ph.D., and John Zaia, M.D., open the first-in-human clinical trial for HIV related malignancies using a lentiviral vector to deliver a triple small RNA based gene therapy.

Richard Jove, Ph.D., is named director of the Beckman Research Institute.

Arthur Riggs, Ph.D., receives California Institute of Technology Distinguished Alumni Award.

The Department of Diabetes and Metabolic Diseases is created.
 

Milestones: 1984-2000

Beckman Research Institute Milestones

1984
The Beckman Research Institute is dedicated.

Arthur Riggs, Ph.D., and Shmuel Cabilly, Ph.D., demonstrate the feasibility and describe a method for making humanized monoclonal antibodies, technology later used in “smart” cancer drugs such as Herceptin, Rituxan and Avastin.


1988
Eugene Roberts, Ph.D., is elected to the National Academy of Sciences in recognition of his work on the existence and function of GABA and other neurotransmitters on the brain and nervous system.


1990
John Rossi, Ph.D., reports first use of RNA to block the progress of the virus that causes AIDS.


1994
The Graduate School of Biological Sciences is chartered.


1996
The Division of Molecular Medicine is created.

Gerd Pfeifer, Ph.D., definitively links smoking to lung cancer, identifying the genetic damage done by the active compounds in cigarettes.


1998
The Division of Molecular Biology is created.

Barry Forman, M.D., Ph.D., identifies the first new steroid-like hormone in 30 years, androstanol, a hormone that reverses or halts gene activity.


1999
The Division of Virology is created.

Arthur Riggs, Ph.D., is named Director of the Beckman Research Institute.


2000
The Center for Biomedicine & Genetics is established to ensure that City of Hope scientific discoveries are efficiently translated from the research lab to the clinical setting.

Milestones: 1952-1983

Beckman Research Institute Milestones

These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
NEWS & UPDATES
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...
  • Cancer cells are masters of survival. Despite excessive damage to their most basic workings and the constant vigilance of the body’s immune system, they manage to persevere. Much of this extraordinary ability to survive falls under the control of proteins bearing the name STAT, short for signal transducer and a...
  • One person receives the breast cancer diagnosis, but the cancer affects the entire family. Couples, in particular, can find the diagnosis and treatment challenging, especially if they have traditional male/female communication styles. “Though every individual is unique, men and women often respond differently d...